TCIM
Transcriptional and immune response regulator
Also known as: C8orf4, hTC-1, TC-1, TC1, TCIM_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NR00
- Gene
- TCIM
- Ensembl
- ENSG00000176907
- Chromosome
- 8
- Canonical length
- 106 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a small, monomeric, predominantly unstructured protein that functions as a positive regulator of the Wnt/beta-catenin signaling pathway. This protein interacts with a repressor of beta-catenin mediated transcription at nuclear speckles. It is thought to competitively block interactions of the repressor with beta-catenin, resulting in up-regulation of beta-catenin target genes. The encoded protein may also play a role in the NF-kappaB and ERK1/2 signaling pathways. Expression of this gene may play a role in the proliferation of several types of cancer including thyroid cancer, breast cancer and hematological malignancies. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
106 residues, UniProt reviewed canonical sequence.
>Q9NR00|TCIM
1 MKAKRSHQAV IMSTSLRVSP SIHGYHFDTA SRKKAVGNIF ENTDQESLER LFRNSGDKKA
61 EERAKIIFAI DQDVEEKTRA LMALKKRTKD KLFQFLKLRK YSIKVHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCIM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 238 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 238 nTPM
- liver: 201 nTPM
- kidney: 189 nTPM
- salivary gland: 166 nTPM
- lung: 159 nTPM
- placenta: 155 nTPM
Single-cell type
- alveolar cells type 2: 771 nCPM
- endometrial glandular cells: 663 nCPM
- prostatic club cells: 453 nCPM
- schwann cells: 436 nCPM
- transitional alveolar cells: 423 nCPM
- salivary acinar cells: 401 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 10 nTPM
- thalamus: 7 nTPM
- cerebral cortex: 5.5 nTPM
- white matter: 5 nTPM
- basal ganglia: 4.3 nTPM
- pons: 3.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0.01
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular response to heat
- negative regulation of Notch signaling pathway
- positive regulation of non-canonical NF-kappaB signal transduction
- regulation of cell cycle G1/S phase transition
- regulation of DNA-templated transcription
- regulation of hemopoiesis
- endothelial cell activation involved in immune response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arginine vasopressin-induced protein 1/transcriptional and immune response regulator
- Thyroid cancer protein 1
- Transcriptional and immune response regulator
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCIM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCIM as an antibody target. Whether an autoantibody or antibody against TCIM could matter depends on whether native TCIM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCIM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCIM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...